Mutsuo Kuba, MD

Articles by Mutsuo Kuba, MD

UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients

ByTokujiro Yano, MD,Shoji Kudoh, MD,Kozo Yoshimori, MD,Tetsuyuki Morikawa, MD,Mutsuo Kuba, MD,Hisanobu Niitani, MD

September 2nd 1997

A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-

Latest Updated Articles

UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
September 2nd 1997

Trending on CancerNetwork

Melanoma Vaccine Receives FDA Fast Track Designation

NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype

Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma

145 Racial Differences in Outcomes and Health Care Utilization Among Patients With HR-Positive, HER2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Real-World Analysis